CPRX: Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) They are up big recently and 8% up today. They are about to release data on CP115 anyway now. Anyone on this stock? I bought when AF wrote that none bearish article I am interested in opinions on CP115 (CP119 data last june was good)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.